SNN

Q: What is the price of Smith & Nephew (SNN) today?

The price of Smith & Nephew (SNN) today is US$ 35,11, with a variation of 27.89% compared to the last year. The price of Smith & Nephew (SNN) started the year trading around US$ 24,58 and today it is at US$ 35,11. Follow the real-time price chart, the historical price of Smith & Nephew (SNN), and stock data from Ibovespa and international markets.

Q: When does Smith & Nephew (SNN) pay dividends?

In the last year, Smith & Nephew (SNN) distributed dividends in the month of May, totaling US$ 0,46. The Dividend Yield for the last 12 months is 2,07%.

Q: Smith & Nephew (SNN) is it worth it?

Currently, Smith & Nephew (SNN) is priced at US$ 35,11, with a P/E of 15,90%, representing a deviation of 19,81% from its historical average P/E. In the last year, the stock showed a variation of 27.89% in its price and distributed US$ 0,46 in dividends, resulting in a Dividend Yield of 2,07%. The total shareholder return was 27,89%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Smith & Nephew (SNN)?

Investing in stocks of Smith & Nephew (SNN) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Smith & Nephew (SNN) yield today?

The yield of Smith & Nephew (SNN) was -6,74% in the last month, 27,89% in the last year and -0,38% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,75 in dividends, um Dividend Yield de 2,07%.If you wanted to buy 100 stocks of Smith & Nephew (SNN) today, the total investment would be US$ 3.511,00, based on the current price of US$ 35,11.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 4.490,22In 5 years: US$ 3.497,66In 10 years: 4.481,44It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Smith & Nephew PLC

Price

US$ 35,11

variation (12m)

27,89%

p/l

15,90

p/vp

2,87

DIVIDEND YIELD

2,07%

price SNN

BVMF

SNN

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of SNN

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-6,74%

3 months

16,91%

1 year

27,89%

2 years

64,92%

5 years

-0,38%

10 years

27,64%

real profitability

profitability minus inflation.

1 month

-6,74%

3 months

16,48%

1 year

22,28%

2 years

50,53%

5 years

-26,38%

10 years

-23,58%

Indicators SNN

check out the fundamentals of Smith & Nephew shares

P/E

15,90

Sector: -1,19 Industry: -3,13

P/SALES RATIO (PSR)

1,35

Sector: 1,95 Industry: 2,78

P/BV

2,87

Sector: 2,22 Industry: 1,88

DIVIDEND YIELD (DY)

2,07%

Sector: - Industry: -

ROA

9,33%

Sector: -26,82% Industry: -52,06%

ROE

18,03%

Sector: -29,98% Industry: -40,51%

ROIC

8,13%

Sector: -411,56% Industry: -412,66%

NET MARGIN

8,51%

Sector: -27,32% Industry: -30,04%

GROSS MARGIN

70,13%

Sector: 43,14% Industry: 44,05%

OPERATING MARGIN

12,91%

Sector: -23,36% Industry: -26,70%

P/EBITDA

5,89

Sector: 0,02 Industry: -2,09

P/EBIT

10,55

Sector: -1,26 Industry: -2,90

P/ASSET

1,48

Sector: 1,27 Industry: 1,41

BVPS

12,67

Sector: 3,73 Industry: 1,64

EPS

2,28

Sector: -0,77 Industry: -1,17

EQUITY / ASSETS

0,52

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

17,08%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

14,92%

Sector: - Industry: -

FAIR PRICE OF Smith & Nephew ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 35,11

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-27,39%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

SNN indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
LLY	54,65	41,10	75,21%	0,69%	US$ 754,20 B	25,91%
ISRG	60,13	9,05	15,04%	0,00%	US$ 162,39 B	28,29%
TMO	31,25	4,06	12,99%	0,30%	US$ 205,37 B	15,12%
SNY	7,88	1,54	19,52%	4,35%	US$ 124,76 B	22,40%
MDT	26,88	2,60	9,68%	2,88%	US$ 125,25 B	13,63%
CVS	17,95	1,27	7,05%	3,43%	US$ 98,10 B	1,40%
ABT	16,70	4,59	27,50%	1,73%	US$ 233,46 B	32,43%
NVS	17,78	6,13	34,49%	2,92%	US$ 257,90 B	25,52%
GSK	13,33	4,47	33,57%	3,74%	US$ 87,13 B	15,70%
BSX	50,82	6,36	12,51%	0,00%	US$ 144,03 B	14,65%
TMDX	38,43	12,37	32,18%	0,00%	US$ 3,93 B	17,65%
HCA	16,16	-82,92	-513,25%	0,66%	US$ 102,66 B	8,61%
DHR	48,94	2,95	6,02%	0,55%	US$ 154,15 B	13,04%
INMD	6,18	1,52	24,58%	0,00%	US$ 954,45 M	42,09%
IDXX	48,24	34,61	71,76%	0,00%	US$ 50,50 B	25,09%
FMS	20,85	0,95	4,56%	2,94%	US$ 15,70 B	3,48%
PHG	92,60	2,21	2,38%	3,16%	US$ 26,49 B	1,45%
HUM	20,85	1,87	8,97%	1,25%	US$ 34,21 B	1,30%
RMD	27,69	6,82	24,62%	0,79%	US$ 40,67 B	27,88%

comparison of SNN with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History SNN

current DY: 2,07%

5-year average DY: 2,70%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	03/10/2025	07/11/2025	0,30000000
Dividends	28/03/2025	28/05/2025	0,46200000
Dividends	04/10/2024	08/11/2024	0,28800000
Dividends	02/04/2024	22/05/2024	0,46200000
Dividends	06/10/2023	01/11/2023	0,28800000
Dividends	31/03/2023	17/05/2023	0,46200000
Dividends	30/09/2022	26/10/2022	0,28800000
Dividends	01/04/2022	11/05/2022	0,46200000
Dividends	01/10/2021	27/10/2021	0,28800000
Dividends	06/04/2021	12/05/2021	0,46200000
Dividends	02/10/2020	28/10/2020	0,28800000
Dividends	03/04/2020	06/05/2020	0,46200000
Dividends	04/10/2019	30/10/2019	0,28800000
Dividends	05/04/2019	08/05/2019	0,44000000
Dividends	05/10/2018	31/10/2018	0,28000000
Dividends	06/04/2018	09/05/2018	0,45400000
Dividends	06/10/2017	01/11/2017	0,24600000
Dividends	31/03/2017	10/05/2017	0,37000000
Dividends	07/10/2016	25/10/2016	0,24600000
Dividends	22/04/2016	11/05/2016	0,38000000
Dividends	09/10/2015	27/10/2015	0,23600000
Dividends	17/04/2015	06/05/2015	0,37200000
Dividends	24/10/2014	11/11/2014	0,22000000
Dividends	22/04/2014	07/05/2014	0,85000000
Dividends	11/10/2013	29/10/2013	0,52000000
Dividends	19/04/2013	08/05/2013	0,81000000
Dividends	12/10/2012	30/10/2012	0,49500000
Dividends	20/04/2012	09/05/2012	0,54000000
Dividends	14/10/2011	01/11/2011	0,33000000
Dividends	03/05/2011	19/05/2011	0,49100000
Dividends	15/10/2010	02/11/2010	0,30000000
Dividends	23/04/2010	12/05/2010	0,44650000
Dividends	16/10/2009	03/11/2009	0,27300000
Dividends	17/04/2009	08/05/2009	0,40600000
Dividends	17/10/2008	07/11/2008	0,24800000
Dividends	18/04/2008	09/05/2008	0,36900000
Dividends	19/10/2007	09/11/2007	0,22550000
Dividends	20/04/2007	21/05/2007	0,33720000
Dividends	20/10/2006	10/11/2006	0,20500000
Dividends	21/04/2006	12/05/2006	0,30500000
Dividends	21/10/2005	21/11/2005	0,18250000
Dividends	22/04/2005	23/05/2005	0,29650000
Dividends	22/10/2004	22/11/2004	0,17500000
Dividends	23/04/2004	24/05/2004	0,27150000
Dividends	15/08/2003	22/09/2003	0,14725000
Dividends	22/04/2003	27/05/2003	0,26975000
Dividends	18/10/2002	25/11/2002	0,15775000
Dividends	19/04/2002	28/05/2002	0,23450000
Dividends	09/11/2001	17/12/2001	0,13825000
Dividends	20/04/2001	29/05/2001	0,22200000
Dividends	10/11/2000	18/12/2000	0,13525000

ABOUT THE COMPANY Smith & Nephew

Smith & Nephew PLC

Average user rating I10

4.0 (2 people)

Estados Unidos

88 years

Foundation: 1937

1999

Year of debut on the stock exchange - 26 years

17.637

Employees

The Company Smith & Nephew PLC (Estados Unidos), is listed on NYSE with a market value of $ 15,87 Billions, having a net worth of $ 5,54 Billions.

With a total of 17.637 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 11,73 Billions, which generated a profit in the amount of $ 998,00 Milhões.

As for its main indicators, the Company has a P/E ratio of 15,90, a P/BV ratio of 2,87 and in the last 12 months the dividend yield of SNN was at 2,07%.

The Company is traded internationally through the ticker SNN.

Market value

US$ 15,87 Billions

Net worth

US$ 5,54 Billions

US$ 5.536.000.000,00

Assets

US$ 10,69 Billions

US$ 10.692.000.000,00

Total Number of Shares

437,00 Milhões

437.000.000

Average Daily Trading Volume

US$ 786,81 Thousand

US$ 786.812,00

Sector

Health

Industry

Medical Supplies and Equipment

SNN

SNN revenue and profits

SNN results

DRAG THE FRAME TO SEE MORE DATA

SNN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 77,90 23,33% (12M)

P/L

17,95

3,43%

ROE

7,05%

P/VP

1,27

CI - Cigna

US$ 300,73 --12,51% (12M)

P/L

14,24

1,91%

ROE

14,37%

P/VP

2,05

CNC - Centene

US$ 35,76 --50,64% (12M)

P/L

17,57

0,00%

ROE

3,96%

P/VP

0,70

HUM - Humana

US$ 280,22 10,41% (12M)

P/L

20,85

1,25%

ROE

8,97%

P/VP

1,87

SNY - Sanofi

US$ 48,09 --8,62% (12M)

P/L

7,88

4,35%

ROE

19,52%

P/VP

1,54

HCA - HCA Healthcare

US$ 415,14 5,77% (12M)

P/L

16,16

0,66%

ROE

-513,25%

P/VP

-82,92

LLY - Eli Lilly

US$ 833,49 --9,64% (12M)

P/L

54,65

0,69%

ROE

75,21%

P/VP

41,10

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 77,90 23,33% (12 M)

P/L

17,95

3,43%

ROE

7,05%

P/VP

1,27

CI - Cigna

US$ 300,73 --12,51% (12 M)

P/L

14,24

1,91%

ROE

14,37%

P/VP

2,05

CNC - Centene

US$ 35,76 --50,64% (12 M)

P/L

17,57

0,00%

ROE

3,96%

P/VP

0,70

HUM - Humana

US$ 280,22 10,41% (12 M)

P/L

20,85

1,25%

ROE

8,97%

P/VP

1,87

SNY - Sanofi

US$ 48,09 --8,62% (12 M)

P/L

7,88

4,35%

ROE

19,52%

P/VP

1,54

HCA - HCA Healthcare

US$ 415,14 5,77% (12 M)

P/L

16,16

0,66%

ROE

-513,25%

P/VP

-82,92

LLY - Eli Lilly

US$ 833,49 --9,64% (12 M)

P/L

54,65

0,69%

ROE

75,21%

P/VP

41,10

Frequently Asked Questions

What is the price of Smith & Nephew (SNN) today?

The price of Smith & Nephew (SNN) today is US$ 35,11, with a variation of 27.89% compared to the last year. The price of Smith & Nephew (SNN) started the year trading around US$ 24,58 and today it is at US$ 35,11. Follow the real-time price chart, the historical price of Smith & Nephew (SNN), and stock data from Ibovespa and international markets.

When does Smith & Nephew (SNN) pay dividends?

In the last year, Smith & Nephew (SNN) distributed dividends in the month of May, totaling US$ 0,46. The Dividend Yield for the last 12 months is 2,07%.

Smith & Nephew (SNN) is it worth it?

Currently, Smith & Nephew (SNN) is priced at US$ 35,11, with a P/E of 15,90%, representing a deviation of 19,81% from its historical average P/E. In the last year, the stock showed a variation of 27.89% in its price and distributed US$ 0,46 in dividends, resulting in a Dividend Yield of 2,07%. The total shareholder return was 27,89%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Smith & Nephew (SNN)?

Investing in stocks of Smith & Nephew (SNN) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Smith & Nephew (SNN) yield today?

The yield of Smith & Nephew (SNN) was -6,74% in the last month, 27,89% in the last year and -0,38% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 0,75 in dividends, um Dividend Yield de 2,07%.

If you wanted to buy 100 stocks of Smith & Nephew (SNN) today, the total investment would be US$ 3.511,00, based on the current price of US$ 35,11.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 4.490,22
In 5 years: US$ 3.497,66
In 10 years: 4.481,44

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

SNN

Smith & Nephew PLC

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of SNN

check out the fundamentals of Smith & Nephew shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 2,07%

5-year average DY: 2,70%

type

date with

payment date

value

ABOUT THE COMPANY Smith & Nephew

Smith & Nephew PLC

Estados Unidos

88 years

1999

17.637

PROFIT X PRICE SNN

SNN results

SNN cash flow

evolution of assets - SNN

SNN balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions